Co-occurring psychiatric disorders in women with addictions

Obstetrics and Gynecology Clinics of North America

Volumn 30, Issue 3, 2003, Pages 469-481

  Chander, Geetanjali ^a   McCaul, Mary E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ALCOHOLISM; ANOREXIA NERVOSA; ANXIETY DISORDER; CHILD SEXUAL ABUSE; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG EFFICACY; EATING DISORDER; FEMALE; GENDER; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; PATHOGENESIS; PATIENT COUNSELING; POSTTRAUMATIC STRESS DISORDER; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RELAPSE; REVIEW; RISK ASSESSMENT;

EID: 0242656365     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(03)00079-2     Document Type: Review

References (64)

1. National Institute of Mental Health. Mental disorders in America. Available at: www.nimh.nih. gov/publicat/numbers/cfm. Accessed June 25, 2003.
2. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
3. Substance Abuse and Mental Health Services Administration. New national study on substance use among women in the United States released. Available at: www.hhs.gov/news/press/1997pres/970922.html. Accessed June 25, 2003.
4. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990;322:95-9.
5. Hanna E, Dufour MC, Elliott S, Stinson F, Harford TC. Dying to be equal: women, alcohol, and cardiovascular disease. Br J Addict 1992;87:1593-7.
6. National Institute on Alcohol Abuse and Alcoholism. Are women more vulnerable to alcohol's effects? Alcohol Alert No. 45. Rockville, MD: NIAAA; 1999.
7. Urbano-Marquez A, Estruch R, Fernandez-Sola J, Nicolas JM, Pare JC, Rubin E. The greater risk of alcoholic cardiomyopathy and myopathy in women compared with men. JAMA 1995;274: 149-54.
8. Miles DR, Svikis DS, Kulstad And JL, Haug NA. Psychopathology in pregnant drug-dependent women with and without comorbid alcohol dependence. Alcohol Clin Exp Res 2001;25: 1012-7.
9. King AC, Bernardy NC, Hauner K. Stressful events, personality, and mood disturbance: gender differences in alcoholics and problem drinkers. Addict Behav 2003;28:171-87.
10. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105.
11. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997;54:313-21.
12. Gomberg ES. Suicide risk among women with alcohol problems. Am J Public Health 1989;79: 1363-5.
13. Helzer JE, Burnam A, McEvoy LT. Alcohol use and dependence. In: Robins LN, Regier DA, editors. Psychiatric disorders in America: the epidemiologic catchment area study. New York: Macmillan; 1991. p. 81-115.
14. Zilberman ML, Tavares H, Blume SB, el Guebaly N. Substance use disorders: sex differences and psychiatric comorbidities. Can J Psychiatry 2003;48:5-13.
15. Dixit AR, Crum RM. Prospective study of depression and the risk of heavy alcohol use in women. Am J Psychiatry 2000;157:751-8.
16. Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry 2001;158:1184-90.
17. Najavits LM, Weiss RD, Shaw SR. The link between substance abuse and posttraumatic stress disorder in women. A research review. Am J Addict 1997;6:273-83.
18. Kendler KS, Bulik CM, Silberg J, Hettema JM, Myers J, Prescott CA. Childhood sexual abuse and adult psychiatric and substance use disorders in women: an epidemiological and cotwin control analysis. Arch Gen Psychiatry 2000;57:953-9.
19. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048-60.
20. Najavits LM, Gastfriend DR, Barber JP, Reif S, Muenz LR, Blaine J, et al. Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Am J Psychiatry 1998;155:214-9.
21. Brown PJ, Recupero PR, Stout R. PTSD substance abuse comorbidity and treatment utilization. Addict Behav 1995;20:251-4.
22. Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 1985;42:1050-5.
23. Cornelius JR, Jarrett PJ, Thase ME, Fabrega Jr H, Haas GL, Jones-Barlock A, et al. Gender effects on the clinical presentation of alcoholics at a psychiatric hospital. Compr Psychiatry 1995;36: 435-40.
24. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-8.
25. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998;23:893-907.
26. Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003;101:374-9.
27. Kelly RH, Danielsen BH, Golding JM, Anders TF, Gilbert WM, Zatzick DF. Adequacy of prenatal care among women with psychiatric diagnoses giving birth in California in 1994 and 1995. Psychiatr Serv 1999;50(12):1584-90.
28. Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clin Psychol Rev 2000;20:173-89.
29. Schuckit MA, Tipp JE, Bucholz KK, Nurnberger Jr JI, Hesselbrock VM, Crowe RR, et al. The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls. Addiction 1997;92:1289-304.
30. Grilo CM, Martino S, Walker ML, Becker DF, Edell WS, McGlashan TH. Psychiatric comorbidity differences in male and female adult psychiatric inpatients with substance use disorders. Compr Psychiatry 1997;38:155-9.
31. Sinha R, Robinson J, Merikangas K, Wilson GT, Rodin J, O'Malley S. Eating pathology among women with alcoholism and/or anxiety disorders. Alcohol Clin Exp Res 1996;20:1184-91.
32. Sinha R, O'Malley SS. Alcohol and eating disorders: implications for alcohol treatment and health services research. Alcohol Clin Exp Res 2000;24:1312-9.
33. Cooley E, Toray T. Disordered eating in college freshman women: a prospective study. J Am Coll Health 2001;49:229-35.
34. Keel PK, Dorer DJ, Eddy KT, Franko D, Charatan DL, Herzog DB. Predictors of mortality in eating disorders. Arch Gen Psychiatry 2003;60:179-83.
35. Greenfield SF, Weiss RD, Muenz LR, Vagge LM, Kelly JF, Bello LR, et al. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry 1998;55:259-65.
36. Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, et al. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997;54: 700-5.
37. Cornelius JR, Salloum IM, Haskett RF, Daley DC, Cornelius MD, Thase ME, et al. Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study. Addict Behav 2000;25: 307-10.
38. Pettinati HM, Volpicelli JR, Luck G, Kranzler HR, Rukstalis MR, Cnaan A. Double-blind clinical trial of sertraline treatment for alcohol dependence. J Clin Psychopharmacol 2001;21:143-53.
39. Roy-Byrne PP, Pages KP, Russo JE, Jaffe C, Blume AW, Kingsley E, et al. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2000;20:129-36.
40. McGrath PJ, Nunes EV, Stewart JW, Goldman D, Agosti V, Ocepek-Welikson K, et al. Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Arch Gen Psychiatry 1996;53:232-40.
41. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 1996;275:761-7.
42. Schmitz JM, Averill P, Stotts AL, Moeller FG, Rhoades HM, Grabowski J. Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug Alcohol Depend 2001;63: 207-14.
43. Cornelius JR, Salloum IM, Thase ME, Haskett RF, Daley DC, Jones-Barlock A, et al. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Psychopharmacol Bull 1998;34: 117-21.
44. Lima MS, Reisser AAP, Soares BGO, Farrell M. Antidepressants for cocaine dependence. (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software; 2003. CD002950.
45. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000;157:1445-52.
46. Willinger U, Lenzinger E, Hornik K, Fischer G, Schonbeck G, Aschauer HN, et al. Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol Alcohol 2002;37:609-12.
47. Driessen M, Meier S, Hill A, Wetterling T, Lange W, Junghanns K. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol 2001;36:249-55.
48. Brown PJ, Stout R, Mueller T. Post-traumatic stress disorder and substance abuse relapse among women: a pilot study. Psychol Addict Behav 1996;10:124-8.
49. Ouimette PC, Brown PJ, Najavits LM. Course and treatment of patients with both substance use and posttraumatic stress disorders. Addict Behav 1998;23:785-95.
50. Bruno F. Buspirone in the treatment of alcoholic patients. Psychopathology 1989;22(Suppl 1): 49-59.
51. Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner P, Brown J, et al. Buspirone treatment of anxious alcoholics. A placebo-controlled trial. Arch Gen Psychiatry 1994;51:720-31.
52. Malcolm R, Anton RF, Randall CL, Johnston A, Brady K, Thevos A. A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 1992;16:1007-13.
53. Schade A, Marquenie LA, Van Balkom AJ, De Beurs E, Van Dyck R, Van Den BW. Do comorbid anxiety disorders in alcohol-dependent patients need specific treatment to prevent relapse? Alcohol Alcohol 2003;38:255-62.
54. Tollefson GD, Lancaster SP, Montague-Clouse J. The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency. Psychopharmacol Bull 1991;27:163-70.
55. Randall CL, Johnson MR, Thevos AK, Sonne SC, Thomas SE, Willard SL, et al. Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety 2001;14:255-62.
56. Substance Abuse and Mental Health Services Administration Office of Applied Statistics. Treatment Episode Data Set (TEDS) 1994-1999. National Admissions to Substance Abuse Treatment Services. DASIS Series: S-16 [Publication no. (SMA) 02-3668]. Rockville, Maryland: SAMHSA; 2001.
57. Chasnoff IJ. Drugs, alcohol, pregnancy, and the neonate. Pay now or pay later. JAMA 1991; 266:1567-8.
58. Beckman LJ, Amaro H. Personal and social difficulties faced by women and men entering alcoholism treatment. J Stud Alcohol 1986;47:135-45.
59. Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse 2003;29:19-53.
60. Dahlgren L, Willander A. Are special treatment facilities for female alcoholics needed? A controlled 2-year follow-up study from a specialized female unit (EWA) versus a mixed male/female treatment facility. Alcohol Clin Exp Res 1989;13:499-504.
61. Grella CE. Women in residential drug treatment: differences by program type and pregnancy. J Health Care Poor Underserved 1999;10:216-29.
62. Copeland J, Hall W, Didcott P, Biggs V. A comparison of a specialist women's alcohol and other drug treatment service with two traditional mixed-sex services: client characteristics and treatment outcome. Drug Alcohol Depend 1993;32:81-92.
63. Volpicelli JR, Markman I, Monterosso J, Filing J, O'Brien CP. Psychosocially enhanced treatment for cocaine-dependent mothers: evidence of efficacy. J Subst Abuse Treat 2000;18:41-9.
64. Horrigan TJ, Schroeder AV, Schaffer RM. The triad of substance abuse, violence, and depression are interrelated in pregnancy. J Subst Abuse Treat 2000;18:55-8.